AbCellera Biologics Inc.

US$11.88As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:ABCLHealthcare
Country USA
PE (Fwd) •••
TSR 6Y CAGR (18.81%)
Div yield —
ROE (17.30%)
Biotechnology
Beta (5Y) 1.59
PE TTM —
TSR TTM 114.05%
Mkt cap US$3.850B
ROIC (42.28%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$13
8.47%
22.39%
Hold 6|1|8|10|4
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.18
0.20
0.20
0.19
26.74%
36.16%
21.00%
5.45%
Revenue$M
373.2
374.4
390.1
401.8
6.26%
5.09%
8.35%
7.18%
Peers (US$3.850B)
Cap (US$)
PE
654.6M
—
3.756B
35.19x
Capital
TTM
5Y
10Y
Leveragex
0.685
0.383
0.287
EBIT/Intx
0.330
0.062
0.057
Own earn%
(89.41)
168.85
190.53
Sh yield%
18.09
28.42
27.55
Owners
Insiders/Inst%
3.36
22.66
Short interest%
5.94
SBC / revenue%
3.74
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
13
Op margin range%
24–37
$1 testx
0.4
Incr. ROIC%
19